Artificial tears.
Showing 1 - 25 of 2,743
Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)
Not yet recruiting
- Nasolacrimal Duct Obstruction
- Thyroid Cancer
- Artificial Tears Methylcellulose
- (no location specified)
Aug 17, 2023
Thyroid Carcinoma, Radioactive Iodine Level Trial in Nashville (Artificial Tears)
Recruiting
- Thyroid Carcinoma
- Radioactive Iodine Level
- Artificial Tears
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 25, 2023
Dry Eye Syndromes Trial in Gainesville (Carboxymethylcellulose (CMC) Artificial Tears, Preservative-free, CMC-free Artificial
Completed
- Dry Eye Syndromes
- Carboxymethylcellulose (CMC) Artificial Tears
- Preservative-free, CMC-free Artificial Tears (control)
-
Gainesville, FloridaUniversity of Florida Oaks Eye Center
Jul 21, 2022
Dry Eye Trial in Berkeley (Systane Complete PF, Refresh Relieva PF, Refresh Optive Mega-3 PF)
Not yet recruiting
- Dry Eye
- Systane Complete PF
- +3 more
-
Berkeley, CaliforniaClinical Research Center, School of Optometry, University of Cal
Jan 20, 2023
Contact Lens Complication Trial in Valladolid (Aquoral Lipo (Esteve), Hyabak (Thea))
Recruiting
- Contact Lens Complication
- Aquoral Lipo (Esteve)
- Hyabak (Thea)
-
Valladolid, SpainIOBA - University of Valladolid
Nov 28, 2022
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative
Completed
- Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)
- +6 more
- Refresh Plus Preservative-free Lubricant Eye Drops
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics - Department of Ophthalmo
Apr 16, 2023
Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal
Recruiting
- Pain
- +2 more
- Use of bromfenac 0.09% to reduce intravitreal injection pain
- Use of artificial tears to reduce intravitreal injection pain
-
Boston, Massachusetts
- +4 more
Nov 8, 2023
Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye
Recruiting
- Dry Eye Disease
- Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
-
Oslo, NorwayThe Norwegian Dry Eye Clinic
Jun 27, 2022
Dry Eye Trial in Shenyang (Diquafosol tetrasodium, Heated eye mask)
Not yet recruiting
- Dry Eye
- Diquafosol tetrasodium
- Heated eye mask
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Jan 31, 2023
Open Angle Glaucoma Trial (NCX 470, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- NCX 470
- Placebo
- (no location specified)
Jul 6, 2023
Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium, 0.1% hyaluronate)
Not yet recruiting
- Diabetic Eye Problems
- 3% Diquafosol tetrasodium
- 0.1% hyaluronate
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Jan 10, 2023
Age-Related Macular Degeneration Trial (Loteprednol Etabonate Ophthalmic Gel [Lotemax], Nepafenac Ophthalmic 0.3% Ophthalmic
Not yet recruiting
- Age-Related Macular Degeneration
- Loteprednol Etabonate Ophthalmic Gel [Lotemax]
- +2 more
- (no location specified)
Sep 14, 2022
Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)
Completed
- Dry Eye Syndromes
- Dextenza 0.4Mg Intracanalicular Insert
- Over the counter Artificial tears
-
Racine, WisconsinThe Eye Center of Racine
Apr 21, 2022
Dry Eye Syndromes Trial in Kowloon, Shatin (TCM ultrasonic atomization treatment with herbal Compound Decoction (CD), TCM
Not yet recruiting
- Dry Eye Syndromes
- TCM ultrasonic atomization treatment with herbal Compound Decoction (CD)
- +4 more
-
Kowloon, Hong Kong
- +3 more
Oct 13, 2023
Cataract Trial in New York (Systane Complete)
Withdrawn
- Cataract
- Systane Complete
-
New York, New YorkWeill Cornell Ophthalmology
Jun 16, 2021
Dry Eye Trial in Pittsburgh (Cyclosporine, Artificial tear)
Not yet recruiting
- Dry Eye
- Cyclosporine
- Artificial tear
-
Pittsburgh, PennsylvaniaUPMC Eye Center
Jan 5, 2022
Microbiota, Ocular Surface Trial in Leuven (Conjunctival swab, Oxybuprocaine Hydrochloride 0.4% Eye Drops, artificial tears)
Completed
- Microbiota
- Ocular Surface
- Conjunctival swab
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven, Department of Ophthalmology
Jul 18, 2022
Dry Eye Disease Trial in Boston (Lotemax, Soothe Tired Eyes Lubricant Eye Drop (Artificial Tears), In Vivo Confocal Microscopy
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
- Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
-
Philadelphia, PennsylvaniaWills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022
Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases Trial in Addis Ababa (Fluorometholone 0.1% Oph Susp, Artificial
Recruiting
- Trachomatous Trichiasis (TT)
- +4 more
- Fluorometholone 0.1% Oph Susp
- Artificial Tears
-
Addis Ababa, EthiopiaMinistry of Science and Higher Education Ethiopia
Jun 24, 2022
Diabetic Retinopathy Trial in Nashville (Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears,
Recruiting
- Diabetic Retinopathy
- Ketorolac 0.45% ophthalmic solution
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 16, 2022
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial
Recruiting
- Keratitis
- Corneal Ulcer
- PXL Platinum 330 system + Riboflavin 0.25% TE Solution
- Sham CXL + Artificial Tears
-
Tampa, Florida
- +7 more
Jul 13, 2022
Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium, 0.1% hyaluronate)
Completed
- Diabetic Eye Problems
- 3% Diquafosol tetrasodium
- 0.1% hyaluronate
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Sep 6, 2021